Skip to main content

Table 2 Baseline characteristics of the study population

From: Improvement cues of lesion absorption using the adjuvant therapy of traditional Chinese medicine Qinbudan tablet for retreatment pulmonary tuberculosis with standard anti-tuberculosis regimen

Characteristics Placebo
n = 88 (%)
QBDT
n = 93 (%)
Statisticsa/bP value
Sociodemographic characteristics
 GenderaMale57 (64.8)60 (64.5)0.000.97
Female31 (35.2)33 (35.5)  
 Source of patientsOutpatient29 (33.0)36 (38.7)0.650.42
Inpatient59 (67.0)57 (61.3)  
 Marital statusUnmarried30 (34.1)34 (36.6)0.120.73
Married58 (65.9)59 (63.4)  
 OccupationWorker13 (14.8)16 (17.2)4.840.85
Farmer15 (17.0)13 (14.0)  
Cadre3 (3.4)4 (4.3)  
Intellectual1 (1.1)3 (3.2)  
Soldier2 (2.3)3 (3.2)  
Staff member10 (11.4)11 (11.8)  
Self-employed5 (5.7)7 (7.5)  
Retired11 (12.5)5 (5.4)  
Unemployed19 (21.6)23 (24.7)  
Other9 (10.2)8 (8.6)  
 Education levelPrimary school16 (18.2)14 (15.1)1.200.75
Junior high school31 (35.2)33 (35.5)  
Senior middle School20 (22.7)27 (29.0)  
University and more21 (23.9)19 (20.4)  
 AgebMean ± SD39.30 ± 14.9537.72 ± 15.330.700.49
 Height (cm)Mean ± SD166.96 ± 6.56167.83 ± 8.800.750.45
 Weight (kg)Mean ± SD56.05 ± 10.0655.77 ± 10.080.190.85
 ComplicationsNo68 (77.3)77 (82.8)0.870.35
Yes20 (22.7)16 (17.2)  
 Clinical courseMean ± SD35.18 ± 47.0237.72 ± 46.300.370.72
Laboratory and imaging examination
 Sputum smear and cultureCulture+ smear+74 (84.1%)81 (87.1%)0.330.56
Culture+ smear-14 (15.9%)12 (12.9%)  
 Drug resistancePyrazinamide15 (17.0%)22 (23.7%)1.220.27
Ethambutol17 (19.3%)15 (16.1%)0.320.57
Streptomycin12 (13.6%)11 (11.8%)0.130.72
 Lung lesionNormal0 (0.0)0 (0.0)01.00
Abnormal88 (100.0)93 (100.0)  
 CavitationNo36 (40.9)42 (45.2)0.330.56
Yes52 (59.1)51 (54.8)  
  1. Note: achi-square test, statistics value, χ2; brank sum test statistics value, Z; QBDT: Qinbudan tablet; CT: Computed tomography